Dominant CTL-inducing epitopes on GAD65 are adjacent to or overlap with dominant Th-inducing epitopes

Clinical Immunology

Volumn 122, Issue 3, 2007, Pages 298-311

  Busick, Rhea Y ^a   Aguilera, Carlos ^a   Quinn, Anthony ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Antigens peptides epitopes; Autoimmunity; Cytotoxic T cells; Diabetes; MHC

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE 65; PEPTIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; FEMALE; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SCID MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; GLUTAMATE DECARBOXYLASE; H-2 ANTIGENS; IMMUNODOMINANT EPITOPES; ISOENZYMES; MICE; MICE, INBRED NOD; MICE, SCID; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 33846844908     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.10.008     Document Type: Article

References (70)

1. Eisenbarth G.S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314 (1986) 1360-1368
2. Delovitch T.L., and Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7 (1997) 727-738
3. Leiter E.H., Prochazka M., and Coleman D.L. The non-obese diabetic (NOD) mouse. Am. J. Pathol. 128 (1987) 380-383
4. Nagata M., Yokono K., Hatamori N., Shii K., and Baba S. The presence of splenic T cells specific for islet cell antigens in nonobese diabetic mice. Clin. Immunol. Immunopathol. 53 (1989) 171-180
5. Wicker L.S., Todd J.A., and Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13 (1995) 179-200
6. Nepom G., Quinn A., Sercarz E., and Wilson D.B. How important is GAD in the etiology of spontaneous disease in human and murine type 1 diabetes?. J. Autoimmun. 20 (2003) 193-194
7. Gauvrit A., Debailleul M., Vu A.T., Sai P., and Bach J.M. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice. Clin. Exp. Immunol. 137 (2004) 253-262
8. Reijonen H., Mallone R., Heninger A.K., Laughlin E.M., Kochik S.A., Falk B., Kwok W.W., Greenbaum C., and Nepom G.T. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53 (2004) 1987-1994
9. Holmberg H., Vaarala O., Sadauskaite-Kuehne V., Ilonen J., Padaiga Z., and Ludvigsson J. Higher prevalence of autoantibodies to insulin and GAD(65) in Swedish compared to Lithuanian children with type 1 diabetes. Diabetes Res. Clin. Pract. 72 (2006) 308-314
10. Maclaren N., Lan M., Coutant R., Schatz D., Silverstein J., Muir A., Clare-Salzer M., She J.X., Malone J., Crockett S., Schwartz S., Quattrin T., DeSilva M., Vander Vegt P., Notkins A., and Krischer J. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J. Autoimmun. 12 (1999) 279-287
11. Boyton R.J., Lohmann T., Londei M., Kalbacher H., Halder T., Frater A.J., Douek D.C., Leslie D.G., Flavell R.A., and Altmann D.M. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int. Immunol. 10 (1998) 1765-1776
12. Danke N.A., Yang J., Greenbaum C., and Kwok W.W. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 25 (2005) 303-311
13. Decochez K., Truyen I., van der Auwera B., Weets I., Vandemeulebroucke E., de Leeuw I.H., Keymeulen B., Mathieu C., Rottiers R., Pipeleers D.G., and Gorus F.K. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. Diabetologia 48 (2005) 687-694
14. Gorus F.K., Goubert P., Semakula C., Vandewalle C.L., De Schepper J., Scheen A., Christie M.R., and Pipeleers D.G. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 40 (1997) 95-99
15. Halbout P., Briand J.P., Becourt C., Muller S., and Boitard C. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J. Immunol. 169 (2002) 2436-2443
16. Knip M., Kukko M., Kulmala P., Veijola R., Simell O., Akerblom H.K., and Ilonen J. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am. J. Med. Genet. 115 (2002) 48-54
17. Medici F., Hawa M.I., Giorgini A., Panelo A., Solfelix C.M., Leslie R.D., and Pozzilli P. Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care 22 (1999) 1458-1461
18. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., and Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
19. Atkinson M.A., Maclaren N.K., and Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39 (1990) 933-937
20. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., and Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366 (1993) 69-72
21. Leslie R.D., Atkinson M.A., and Notkins A.L. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia 42 (1999) 3-14
22. Li A.F., Hough J., Henderson D., and Escher A. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine 22 (2004) 1751-1763
23. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., Krischer J., and Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95 (1995) 628-634
24. Tian J., Clare-Salzler M., Herschenfeld A., Middleton B., Newman D., Mueller R., Arita S., Evans C., Atkinson M.A., Mullen Y., Sarvetnick N., Tobin A.J., Lehmann P.V., and Kaufman D.L. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2 (1996) 1348-1353
25. Tisch R., Wang B., and Serreze D.V. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163 (1999) 1178-1187
26. g7 in non-obese diabetic mice. Immunogenetics 46 (1997) 29-34
27. Wegmann D.R., Gill R.G., Norbury-Glaser M., Schloot N., and Daniel D. Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7 (1994) 833-843
28. Miller B.J., Appel M.C., O'Neil J.J., and Wicker L.S. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140 (1988) 52-58
29. Christianson S.W., Shultz L.D., and Leiter E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42 (1993) 44-55
30. Serreze D.V., Chapman H.D., Varnum D.S., Gerling I., Leiter E.H., and Shultz L.D. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 158 (1997) 3978-3986
31. Sumida T., Furukawa M., Sakamoto A., Namekawa T., Maeda T., Zijlstra M., Iwamoto I., Koike T., Yoshida S., Tomioka H., et al. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6 (1994) 1445-1449
32. Katz J., Benoist C., and Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23 (1993) 3358-3360
33. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., and Serreze D.V. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12538-12543
34. Kay T.W., Campbell I.L., Oxbrow L., and Harrison L.C. Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia 34 (1991) 779-785
35. Wang B., Gonzalez A., Benoist C., and Mathis D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26 (1996) 1762-1769
36. g7 and autoimmune diabetes. Science 288 (2000) 505-511
37. McInerney M.F., Rath S., and Janeway Jr. C.A. Exclusive expression of MHC class II proteins on CD45+ cells in pancreatic islets of NOD mice. Diabetes 40 (1991) 648-651
38. Rabinovitch A., and Suarez-Pinzon W.L. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 55 (1998) 1139-1149
39. Kang S.M., Schneider D.B., Lin Z., Hanahan D., Dichek D.A., Stock P.G., and Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. [see comments]. Nat. Med. 3 (1997) 738-743
40. Yamanouchi J., Verdaguer J., Han B., Amrani A., Serra P., and Santamaria P. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J. Immunol. 171 (2003) 6900-6999
41. Young L.H., Peterson L.B., Wicker L.S., Persechini P.M., and Young J.D. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J. Immunol. 143 (1989) 3994-3999
42. Haskins K., and McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249 (1990) 1433-1436
43. Quinn A., McInerney M.F., and Sercarz E.E. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J. Immunol. 167 (2001) 1748-1757
44. Quinn A., McInerney B., Reich E.P., Kim O., Jensen K.P., and Sercarz E.E. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J. Immunol. 166 (2001) 2982-2991
45. Quinn A., McInerney M., Huffman D., McInerney B., Mayo S., Haskins K., and Sercarz E. T cells to a dominant epitope of GAD65 express a public CDR3 motif. Int. Immunol. 18 (2006) 967-979
46. Glimcher L.H., McKean D.J., Choi E., and Seidman J.G. Complex regulation of class II gene expression: analysis with class II mutant cell lines. J. Immunol. 135 (1985) 3542-3550
47. Ljunggren H.G., Stam N.J., Ohlen C., Neefjes J.J., Hoglund P., Heemels M.T., Bastin J., Schumacher T.N., Townsend A., Karre K., et al. Empty MHC class I molecules come out in the cold. Nature 346 (1990) 476-480
48. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145 (1991) 185-192
49. Nagata M., Yokono K., Hayakawa M., Kawase Y., Hatamori N., Ogawa W., Yonezawa K., Shii K., and Baba S. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J. Immunol. 143 (1989) 1155-1162
50. Townsend A., Ohlen C., Bastin J., Ljunggren H.G., Foster L., and Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. [see comments]. Nature 340 (1989) 443-448
51. Bowie L., Tite J., and Cooke A. Generation and maintenance of autoantigen-specific CD8(+) T cell clones isolated from NOD mice. J. Immunol. Methods 228 (1999) 87-95
52. Carter L.L., and Dutton R.W. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J. Immunol. 155 (1995) 1028-1031
53. Sad S., Marcotte R., and Mosmann T.R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2 (1995) 271-279
54. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., and Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. [see comments]. Nature 393 (1998) 480-483
55. Krzych U., Fowler A.V., and Sercarz E.E. Repertoires of T cells directed against a large protein antigen, beta-galactosidase: II. Only certain T helper or T suppressor cells are relevant in particular regulatory interactions. J. Exp. Med. 162 (1985) 311-323
56. Shivakumar S., Sercarz E.E., and Krzych U. The molecular context of determinants within the priming antigen establishes a hierarchy of T cell induction: T cell specificities induced by peptides of beta-galactosidase vs. the whole antigen. Eur. J. Immunol. 19 (1989) 681-687
57. Wen L., Wong F.S., Burkly L., Altieri M., Mamalaki C., Kioussis D., Flavell R.A., and Sherwin R.S. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. J. Clin. Invest. 102 (1998) 947-957
58. Horwitz M.S., Ilic A., Fine C., Balasa B., and Sarvetnick N. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin. Immunol. 110 (2004) 134-144
59. Zekzer D., Wong F.S., Ayalon O., Millet I., Altieri M., Shintani S., Solimena M., and Sherwin R.S. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101 (1998) 68-73
60. Cetkovic-Cvrlje M., Gerling I.C., Muir A., Atkinson M.A., Elliot J.F., and Leiter E.H. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens. [published erratum appears in Diabetes 1998 Feb;47(2):303]. Diabetes 46 (1997) 1975-1982
61. Lernmark A. Glutamic acid decarboxylase-gene to antigen to disease. J. Intern. Med. 240 (1996) 259-277
62. Wong F.S., Karttunen J., Dumont C., Wen L., Visintin I., Pilip I.M., Shastri N., Pamer E.G., and Janeway Jr. C.A. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. [see comments]. Nat. Med. 5 (1999) 1026-1031
63. Videbaek N., Harach S., Phillips J., Hutchings P., Ozegbe P., Michelsen B.K., and Cooke A. An islet-homing NOD CD8+ cytotoxic T cell clone recognizes GAD65 and causes insulitis. J. Autoimmun. 20 (2003) 97-109
64. Utsugi T., Yoon J.W., Park B.J., Imamura M., Averill N., Kawazu S., and Santamaria P. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Diabetes 45 (1996) 1121-1131
65. Cresswell P., Ackerman A.L., Giodini A., Peaper D.R., and Wearsch P.A. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207 (2005) 145-157
66. Rammensee H.G., Falk K., and Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11 (1993) 213-244
67. Romero P., Corradin G., Luescher I.F., and Maryanski J.L. H-2Kd-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174 (1991) 603-612
68. Yang Y., Charlton B., Shimada A., Dal Canto R., and Fathman C.G. Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4 (1996) 189-194
69. Ahlers J.D., Belyakov I.M., Terabe M., Koka R., Donaldson D.D., Thomas E.K., and Berzofsky J.A. A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13020-13025
70. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., and Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587